Cargando…

Evidence for direct interaction between the oncogenic proteins E6 and E7 of high-risk human papillomavirus (HPV)

Human papillomaviruses (HPVs) are DNA tumor viruses that infect mucosal and cutaneous epithelial cells of more than 20 vertebrates. High-risk HPV causes about 5% of human cancers worldwide, and the viral proteins E6 and E7 promote carcinogenesis by interacting with tumor suppressors and interfering...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, JiaWen, Lilie, Hauke, Kalbacher, Hubert, Roos, Nora, Frecot, Desiree Isabella, Feige, Maximilian, Conrady, Marcel, Votteler, Tobias, Cousido-Siah, Alexandra, Bartoli, Giada Corradini, Iftner, Thomas, Trave, Gilles, Simon, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372912/ https://www.ncbi.nlm.nih.gov/pubmed/37354975 http://dx.doi.org/10.1016/j.jbc.2023.104954

Ejemplares similares

Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
por: Martinez-Zapien, Denise, et al.
Publicado: (2016)

Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5
por: Wetherill, Laura F., et al.
Publicado: (2018)

Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand**
por: Ramirez, Juan, et al.
Publicado: (2015)

An enhanced triple fluorescence flow-cytometry-based assay shows differential activation of the Notch signaling pathway by human papillomavirus E6 proteins
por: Lim, JiaWen, et al.
Publicado: (2022)

In North America, Some Ovarian Cancers Express the Oncogenes of Preventable Human Papillomavirus HPV-18
por: Roos, Patrick, et al.
Publicado: (2015)

REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
por: Zhou, Shu-Guang, et al.
Publicado: (2022)

A Non-oncogenic HPV 16 E6/E7 Vaccine Enhances Treatment of HPV Expressing Tumors
por: Wieking, Bryant G., et al.
Publicado: (2012)

Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis
por: Aggarwal, Charu, et al.
Publicado: (2020)

Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer
por: Faridi, Rabia, et al.
Publicado: (2011)

Endogenous oestradiol and progesterone as predictors of oncogenic human papillomavirus (HPV) persistence
por: Fischer, Susanne, et al.
Publicado: (2022)

Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker
por: Fontecha, Nerea, et al.
Publicado: (2016)

RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection
por: Fontecha, Nerea, et al.
Publicado: (2017)

Oncogenic comparison of human papillomavirus type 58 E7 variants
por: Law, Priscilla TY, et al.
Publicado: (2018)

Genome Plasticity in Papillomaviruses and De Novo Emergence of E5 Oncogenes
por: Willemsen, Anouk, et al.
Publicado: (2019)

Interaction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral Replication
por: Dreer, Marcel, et al.
Publicado: (2016)

Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in Ghana
por: Kaba, Gladys, et al.
Publicado: (2023)

High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
por: Zheng, Yunji, et al.
Publicado: (2022)

Bovine papillomavirus on the scene of crime: is E5 oncogene the only guilty party?
por: Borzacchiello, Giuseppe
Publicado: (2013)

An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein
por: Belyaeva, Tamara A., et al.
Publicado: (2014)

HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes
por: Yuan, Hang, et al.
Publicado: (2017)

Genetic variability in the E6 and E7 oncogenes of HPV52 and its prevalence in the Taizhou area, China
por: Yang, Zhi, et al.
Publicado: (2022)

Development and validation of a multiplex qPCR assay for detection and relative quantification of HPV16 and HPV18 E6 and E7 oncogenes
por: Bordigoni, Alexia, et al.
Publicado: (2021)

Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential
por: Zehbe, Ingeborg, et al.
Publicado: (2011)

Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
por: Paolini, Francesca, et al.
Publicado: (2021)

The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target
por: Kuroda, M, et al.
Publicado: (2005)

Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma
por: Hirshoren, Nir, et al.
Publicado: (2014)

Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines
por: Hoppe-Seyler, Karin, et al.
Publicado: (2017)

The E6AP Binding Pocket of the HPV16 E6 Oncoprotein Provides a Docking Site for a Small Inhibitory Peptide Unrelated to E6AP, Indicating Druggability of E6
por: Zanier, Katia, et al.
Publicado: (2014)

Editorial expression of concern: Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression
por: Faghihloo, E., et al.
Publicado: (2020)

Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation in vivo
por: Kuehner, Franziska, et al.
Publicado: (2023)

5-aza-2′-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells
por: Stich, Maximilian, et al.
Publicado: (2016)

Genetic variability in E6 and E7 oncogenes of human papillomavirus Type 16 from Congolese cervical cancer isolates
por: Boumba, Luc Magloire Anicet, et al.
Publicado: (2015)

Characterization of Intra-Type Variants of Oncogenic Human Papillomaviruses by Next-Generation Deep Sequencing of the E6/E7 Region
por: Lavezzo, Enrico, et al.
Publicado: (2016)

Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells
por: Honegger, Anja, et al.
Publicado: (2015)

Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18
por: Díaz-Tejeda, Yakelin, et al.
Publicado: (2021)

HPV16-E6/E7 Oncogene Mutation and p53 Expression among Indonesian Women with Cervical Cancer
por: Mahendra, I Nyoman Bayu, et al.
Publicado: (2022)

Structural variability of E. coli thioredoxin captured in the crystal structures of single-point mutants
por: Noguera, Martín E., et al.
Publicado: (2017)

hnRNP E1 Regulates HPV16 Oncogene Expression and Inhibits Cervical Cancerization
por: Song, Li, et al.
Publicado: (2022)

E7 Oncogene HPV58 Variants Detected in Northeast Brazil: Genetic and Functional Analysis
por: Chagas, Bárbara Simas, et al.
Publicado: (2023)

Oncogenic human papillomaviruses
por: McBride, Alison A.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_al5vd4sugfmtvmj7hc9qu39gvo